Novugen

Novugen, with the slogan "Accelerating Affordable Medicine," is a subsidiary of UAE-based SciTech International. It operates as a vertically integrated pharmaceutical company, specializing in Active Pharmaceutical Ingredients (API), Finished Products Research & Development (R&D), and manufacturing across therapeutic areas, including oncology. With 30 years of experience in global healthcare, Novugen aims to bring technology-intensive products to the market, ensuring early access to affordable, high-quality drugs for patients worldwide. Notably, the company's manufacturing facilities in Malaysia are the first in the country to receive USFDA approval and are the only ones in Southeast Asia. This facility focuses on oral solid dosage forms for general medicines and the manufacturing of highly potent Oncology drugs. Furthermore, the manufacturing site is Halal compliant in response to the increasing demand for Halal products. Despite its commitment to providing valuable information, Novugen emphasizes respectful interactions on its page and reserves the right to remove inappropriate content. Founded in 2015, Novugen operates in the Manufacturing and Pharmaceutical industries. At present, there are no records of recent investments or involved investors.